François Bénard Selected Research

Bombesin

3/2022	A Radiotracer for Molecular Imaging and Therapy of Gastrin-Releasing Peptide Receptor-Positive Prostate Cancer.
1/2019	Positron Emission Tomography Imaging of the Gastrin-Releasing Peptide Receptor with a Novel Bombesin Analogue.
4/2015	(18)F-AmBF3-MJ9: a novel radiofluorinated bombesin derivative for prostate cancer imaging.
8/2012	Novel radiolabeled peptides for breast and prostate tumor PET imaging: (64)Cu/and (68)Ga/NOTA-PEG-[D-Tyr(6),βAla(11),Thi(13),Nle(14)]BBN(6-14).
4/2008	Targeting gastrin-releasing peptide receptors of prostate cancer cells for photodynamic therapy with a phthalocyanine-bombesin conjugate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

François Bénard Research Topics

Disease

72	Neoplasms (Cancer) 02/2024 - 01/2002
37	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 06/2005
15	Breast Neoplasms (Breast Cancer) 12/2022 - 08/2002
9	Melanoma (Melanoma, Malignant) 10/2022 - 01/2017
8	Neoplasm Metastasis (Metastasis) 02/2024 - 06/2005
5	Carcinoma (Carcinomatosis) 02/2024 - 05/2007
4	Lymphoma (Lymphomas) 02/2024 - 01/2002
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2023 - 09/2014
3	Hypoxia (Hypoxemia) 01/2023 - 01/2017
3	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 08/2003
3	Heart Failure 11/2014 - 10/2003
2	Infections 01/2022 - 01/2012
2	Inflammation (Inflammations) 08/2020 - 03/2015
2	Cardiotoxicity 11/2014 - 02/2012
1	Xerostomia 01/2024
1	Carcinogenesis 04/2023
1	Hemorrhage 02/2023
1	Ovarian Epithelial Carcinoma 01/2023
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021
1	Obesity 08/2020
1	Chronic Pain 08/2020

Drug/Important Bio-Agent (IBA)

20	AntigensIBA 02/2024 - 01/2018
17	Peptides (Polypeptides)IBA 10/2023 - 08/2011
10	Bombesin Receptors (Bombesin Receptor)IBA 02/2023 - 04/2008
9	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2005
8	RadiopharmaceuticalsIBA 02/2024 - 08/2002
8	Biomarkers (Surrogate Marker)IBA 02/2024 - 10/2009
7	2- (3- (1- carboxy- 5- ((6- fluoropyridine- 3- carbonyl)amino)pentyl)ureido)pentanedioic acidIBA 04/2024 - 11/2019
7	Type 1 Melanocortin ReceptorIBA 01/2022 - 01/2017
7	LigandsIBA 01/2022 - 01/2005
6	Estrogen ReceptorsIBA 01/2012 - 08/2004
5	AcidsIBA 05/2023 - 01/2017
5	BombesinIBA 03/2022 - 04/2008
5	Melanocyte-Stimulating Hormones (MSH)IBA 05/2020 - 01/2017
5	Bradykinin B1 ReceptorIBA 01/2017 - 03/2015
5	Hormones (Hormone)IBA 05/2007 - 08/2004
4	Radioisotopes (Radionuclides)IBA 02/2023 - 01/2017
4	EnzymesIBA 01/2023 - 01/2005
4	Carbonic Anhydrase IXIBA 01/2023 - 09/2015
4	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 06/2022 - 04/2015
4	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2021 - 02/2010
4	AlbuminsIBA 01/2021 - 04/2006
4	Chelating AgentsIBA 01/2021 - 08/2011
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2006 - 08/2003
3	Somatostatin Receptors (Somatostatin Receptor)IBA 10/2023 - 09/2014
3	AndrogensIBA 09/2022 - 06/2005
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 02/2012
3	MetalsIBA 01/2020 - 08/2012
3	Amino Acids FDA Link 07/2019 - 04/2003
3	Acetates (Acetic Acid Esters)FDA Link 11/2018 - 07/2008
3	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 05/2007
3	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 08/2012 - 08/2011
2	Urea (Carbamide)FDA LinkGeneric 06/2023 - 01/2022
2	pyridineIBA 03/2023 - 11/2019
2	FluoridesIBA 12/2022 - 10/2010
2	Trastuzumab (Herceptin)FDA Link 06/2022 - 01/2021
2	enzalutamideIBA 10/2021 - 03/2018
2	Glutamic Acid (Glutamate)FDA Link 01/2021 - 01/2019
2	Sodium Glutamate (Accent)IBA 01/2021 - 12/2018
2	177Lu-PSMA-617IBA 01/2021 - 11/2018
2	IsotopesIBA 05/2020 - 01/2018
2	Prostate-Specific Antigen (Semenogelase)IBA 11/2019 - 05/2007
2	Integrin alpha4beta1 (VLA-4)IBA 01/2019 - 01/2018
2	gallium 68 PSMA-11IBA 12/2018 - 01/2018
2	Phenobarbital (Luminal)FDA Link 01/2017 - 10/2009
2	Complement System Proteins (Complement)IBA 01/2017 - 01/2005
2	Acetazolamide (Diamox)FDA LinkGeneric 03/2016 - 09/2015
2	KallidinIBA 08/2015 - 01/2015
2	acetoacetic acid (acetoacetate)IBA 11/2014 - 07/2008
2	KetonesIBA 11/2014 - 07/2008
2	A-factor (Streptomyces)IBA 08/2012 - 04/2008
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2012 - 04/2007
1	benzo(h)quinolineIBA 02/2024
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 10/2023
1	Fluorescent Dyes (Fluorescent Probes)IBA 10/2023
1	EDDA (NiEDDA)IBA 06/2023
1	Serine Proteases (Serine Protease)IBA 05/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 04/2023
1	quinolineIBA 03/2023
1	Technetium Tc 99m MedronateIBA 12/2022
1	bombesin (7-14)IBA 06/2022
1	4,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA 06/2022
1	Epoxy Resins FDA Link 01/2022
1	SodiumIBA 01/2022
1	abirateroneIBA 10/2021
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Lysine (L-Lysine)FDA Link 01/2021
1	Dacarbazine (DIC)FDA LinkGeneric 01/2021
1	KininsIBA 08/2020
1	NucleosidesIBA 05/2020

Therapy/Procedure

30	Therapeutics 02/2024 - 08/2003
8	Radiotherapy 01/2024 - 01/2016
6	Precision Medicine 02/2024 - 01/2017
6	Drug Therapy (Chemotherapy) 01/2021 - 01/2005
4	Castration 01/2023 - 03/2018
3	Prostatectomy (Retropubic Prostatectomy) 03/2022 - 02/2007
1	Brachytherapy 01/2022